Do Drugs and Hospital Supplies Mix?
Recent moves by McKesson, in its acquisition of medical/surgical supplier General Medical, and Bergen Brunswig, in the launch of its Inteplex program, have revived an old debate--does the merger of pharmaceutical and med/surg supply make sense? Distribution experts say, No. But a new breed of customer, integrated delivery networks, may cause people to change their minds.
You may also be interested in...
The Italian firm's move to license Isturisa from Novartis last year is paying dividends already and Recordati has already tripled its peak sales forecast for the Cushing's therapy.
Pfizer is up against AstraZeneca and Sanofi in developing competing approaches to tackling the unmet need in respiratory syncytial virus (RSV). But earlier failures mean all players will need much more data to sway regulators.
Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Fifty-two guidance documents have been posted on the tracker since its last update.